Circulating Antibodies to Dietary Proteins in Ulcerative Colitis

Wright, Ralph; Truelove, S. C.
July 1965
British Medical Journal;7/17/1965, Vol. 2 Issue 5454, p142
Academic Journal
No abstract available.


Related Articles

  • Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's. Main, Janice; McKenzie, Hamish; Yeaman, Grant R.; Kerr, Michael A.; Robson, Deborah; Pennington, Christopher R.; Parratt, David // BMJ: British Medical Journal (International Edition);10/29/88, Vol. 297 Issue 6656, p1105 

    Examines the response of antibody to Saccharomyces cerevisiae, a dietary antigen in patients with Crohn's disease. Uses of S. cerevisiae; Role of S. cerevisiae in the occurrence of Crohn's disease; Comparison on antibody response between patients with Crohn's disease and ulcerative colitis.

  • A randomized controlled trial of a humanized Alpha4Beta7 antibody in Ulcerative Colitis (UC). Feagan, Brian; Greenberg, Gordon; Wild, Gary; McDonald, John; Fedorak, Richard; Pare, Pierre; Kishimoto, Kei; Guitterez-Ramos, Jose-Carlos; Krop, Julie; Vandervoort, Margaret // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS248 

    An abstract of the article concerning ulcerative colitis and randomized trial of antibody is presented.

  • Dietary Antigens in Crohn's Disease: Antibodies to Porcine Pancreatic Amylase. Hideki Suzuki; Yoshihiro Fukuda; Hiromasa Koizuka; Toshihiko Tomita; Kazutoshi Hori; Manabu Suzuki; O'Morain, Colm // American Journal of Gastroenterology;Mar2008, Vol. 103 Issue 3, p656 

    OBJECTIVES: There is no clear evidence that dietary proteins aggravate Crohn's disease (CD). We aimed to clarify the antibody response to dietary proteins in CD. METHODS: Antibody to porcine pancreatic amylase (PPA) a protease-resistant dietary protein (anti-PPA), was examined in CD patients (N...

  • Abnormalities in colonic mucin may contribute to the persistence of colonic mucosal inflammation.  // Journal of Gastroenterology;2000, Vol. 35 Issue 1, p71 

    Editorial. Deals with the possible contribution of the abnormalities in colonic mucin to the persistence of colonic mucosal inflammation. Percentage of ulcerative colitis patients with circulating antibodies to colonocytes; Number of reported mucin genes; Description of MUC2 mucin; Candidate...

  • Circulating autoantibodies against purified colonic mucin in ulcerative colitis. Takaishi, Hiromasa; Ohara, Susumu; Hotta, Kyoko; Yajima, Tomoharu; Kanai, Takanori; Inoue, Nagamu; Iwao, Yasushi; Watanabe, Mamoru; Ishii, Hiromasa; Hibi, Toshifumi; Takaishi, H; Ohara, S; Hotta, K; Yajima, T; Kanai, T; Inoue, N; Iwao, Y; Watanabe, M; Ishii, H; Hibi, T // Journal of Gastroenterology;2000, Vol. 35 Issue 1, p20 

    To clarify the role of colonic mucin in the autoimmune process of ulcerative colitis, circulating antibodies against human colonic mucin were investigated. Purified colonic mucin, obtained from human colonic mucosa by gel filtration, using a Bio-Gel A-1.5-m column and CsCl equilibrium density...

  • THE PRESENT MANAGEMENT OF ULCERATIVE COLITIS WITH SPECIAL EMPHASIS ON SPRUE DIET. Monat, Henry A. // American Journal of Gastroenterology;Mar1957, Vol. 27 Issue 3, p259 

    Discusses the management of several types of ulcerative colitis. Chemical treatment; Emotional treatment; Dietary treatment.

  • Tumor Necrosis Factor-α Antagonism Improves Endothelial Dysfunction in Patients With Crohn's Disease. Schinzari, F.; Armuzzi, A.; De Pascalis, B.; Mores, N.; Tesauro, M.; Melina, D.; Cardillo, C. // Clinical Pharmacology & Therapeutics;Jan2008, Vol. 83 Issue 1, p70 

    This study assessed the presence of endothelial dysfunction in patients with inflammatory bowel diseases (IBDs) and evaluated the possible role of tumor necrosis factor (TNF)-α in the pathophysiology of this abnormality. Similar elevations in circulating markers of inflammation (C-reactive...

  • Prevalence and clinical utility of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. Yamamoto-Furusho, Jesus K; Reyes, Edgardo; Takahashi, Takeshi; Uscanga, Luis // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS237 

    An abstract of the article concerning clinical utility and prevalence of anti-neutropil cytoplasmic antibodies and perinuclear in ulcerative colitis is presented.

  • Ulcerative Colitis.  // Current Medical Literature: Gastroenterology;2008, Vol. 27 Issue 2, p55 

    The article presents abstracts on ulcerative colitis which include "A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis" and "Clinical Trial: Oral Prednisolone Metasulfobenzoate (Predocol) Vs. Oral Prednisolone for Active...

  • Antineutrophil cytoplasmic antibody and the gastroenterologist. Dickey, William; McMillan, Stanley // Journal of the Royal Society of Medicine;Sep1992, Vol. 85 Issue 9, p518 

    The article discusses the antineutrophil cytoplasmic antibody (ANCA) as a diagnostic test. It describes the ANCA associated with ulcerative colitis. It describes ulcerative colitis as an autoimmune disorder. The ANCA in ulcerative colitis cannot be used to monitor disease activity and response...


Read the Article

Other Topics